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Abstract
Neurotrophins (NTs) are a family of secreted growth factor proteins primarily involved in the regulation of survival and
appropriate development of neural cells, functioning by binding to their specific (TrkA, TtkB, and TrkC) and/or common
NGFR receptor. NGFR is the common receptor of NTs, binding with low-affinity to all members of the family. Among
different functions assigned to NGFR, it is also involved in apoptosis induction and tumorigenesis processes. Interestingly,
some of the functions of NGFR appear to be ligand-independent, suggesting a probable involvement of non-coding RNA
residing within the sequence of the gene. Here, we are reporting the existence of a conserved putative microRNA, named
Hsa-mir-6165 [EBI accession#: FR873488]. Transfection of a DNA segment corresponding to the pre-mir-6165 sequence in
Hela cell line caused the generation of mature exogenous mir-6165 (a ,200,000 fold overexpression). Furthermore, using
specific primers, we succeeded to detect the endogenous expression of mir-6165 in several glioma cell lines and glioma
primary tumors known to express NGFR. Similar to the pro-apoptotic role of NGFR in some cell types, overexpression of pre-
mir-6165 in U87 cell line resulted in an elevated rate of apoptosis. Moreover, coordinated with the increased level of mir-
6165 in the transfected U87 cell line, two of its predicted target genes (Pkd1 and DAGLA) were significantly down-regulated.
The latter findings suggest that some of the previously attributed functions of NGFR could be explained indirectly by co-
transcription of mir-6165 in the cells.
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Introduction
Nerve growth factor receptor (NGFR) (NC_000017.10) is a
multi-functional cell surface receptor in many human cell types
including some adult brain cells. This gene can induce apoptosis
and is also involved in injury, nervous system development and
regeneration [1]. NGFR expression is induced in many patholog-
ical conditions, such as atherosclerosis [2], ischemia [3], diabetes
[4–5] and cancer [6–14]. NGFR acts as a tumor suppressor in
most cases of cancers, causing apoptosis and suppression of
metastatic invasion. Contrary, NGFR can induce invasion and
metastasis in glioma [15] and melanoma [9].
There are some transcription factors which regulate NGFR
gene expression in conditions like hypo-osmolar stress and injuries
[16]. There are also an increasing list of ligands, co-receptors and
adaptor proteins which interact with NGFR, involving this gene in
different signaling pathways ending to cell death and/or survival
[17]. Recent publications suggest a ligand independent activation
and also a non-NGF ligand activation of NGFR signaling [18–19].
It remains to be found if non-coding RNAs such as miRNAs are
involved in this regulation as well.
miRNAs are endogenous small non-coding RNAs about 21–
23nt, each capable of interfering with dozens of target mRNAs
through complete or partial complementarities. The miRNA
genes are transcribed by RNA polymerase II or III and the
primary transcript termed pri-miRNA, is quickly trimmed into
,70nt long pre-miRNA precursor. The pre-miRNAs are then
transported to the cytoplasm and further processed to functional
miRNAs, which exert their regulatory functions by complemen-
tary binding to their target genes [20]. To date, more than 1000
human miRNAs have been published in mirbase database [21],
among which 40% are located within introns of protein-coding
‘host’ genes [22–27] and appear to be conserved across the species.
Identification of novel miRNA by forward genetics has been
tedious as a result of the small sizes of miRNAs as well as their
tolerance to mutations that do not affect their seed sequences [28].
On the other hand, the computational prediction of non-coding
RNAs (ncRNAs) has proven to be fast, cheap and effective [29–
30]. After prediction of a miRNA gene, experimental verification
is necessary to demonstrate its exact mature sequence and
function. Briefly, some major characteristics such as the hairpin-
shaped stem loop structure, high evolutionary conservation and
high minimal folding free energy are important features used in
the computational identification of novel miRNAs [31]. Here
bioinformatics tools were used to search for hairpin structures
within the NGFR intronic and exonic regions. One of the NGFR
resided hairpin structures showed all the bioinformatics characters
of producing a real miRNA. Later, accumulative experimental
evidences for the first time showed the presence and the
functionality of this novel NGFR intronic miRNA in human cells.
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Gene and primer name Sequence 59 to 39
NGFR Forward: CCGAGGCACCACCGACAACC Reverse: GGGCGTCTGGTTCACTGGCC
U48 Forward: TGACCCCAGGTAACTCTGAGTGTGT
Precursor Forward: CAGCAGGTCAGCAGGAGGTGAGGGG Reverse: GGGAGGGGCTGGAGCCAGGACAGG




Anchored Oligo dT GCGTCGACTAGTACAACTCAAGGTTCTTCCAGTCACGACG (T)17N
Universal outer primers (a) AACTCAAGGTTCTTCCAGTCACG
(b) GCGTCGACTAGTACAACTCAAG
Pkd1 Forward: GTTCTCAGGCCTCCACGCTGAG Reverse: AGGGCCAGCACACCAGACTCTTAGA
DAGLA Forward: ACTGGCCTTGCCCTGGAGCT Reverse: CGCAACCACTGGCGACAGCA
doi:10.1371/journal.pone.0035561.t001
Figure 1. Prediction of pre-mir-6165 within the 4
th intron of human NGFR gene. A) Position of predicted hairpin structure within the
human NGFR gene is shown in the 4
th intorn. This hairpin is predicted to produce Hsa-mir-6165 which is shown as red colored sequence on the stem
loop. B) Prediction of Drosha enzyme 5’ and 3’ cutting sites on the sequence of stem loop by Microprocessor SVM. C) Blat search result shows a strong
conservation of Hsa-mir-6165 between human, rhesus, dog and elephant.
doi:10.1371/journal.pone.0035561.g001
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Bioinformatics Tools and Studies
To search for the possible hairpin structures within the area of
interest, SCC profiler [32] and miPRED [33] online classifier
[http://www.bioinf.seu.edu.cn/miRNA] programs were em-
ployed. For the identification of putative miRNA precursors in
NGFR introns CID-miRNA [34] was used along with the
prediction of Dorsha processing sites using Microprocessor SVM
(https://demo1.interagon.com/miRNA/) program [35]. Mireval
[36] (http://tagc.univ-mrs.fr/mireval/) and mirbase (http://www.
mirbase.org/index.shtml) databases were also used to determine
the degree of conservation of mir-6165 and its precursor sequence
along with blat [37] search against human genome and other
organisms.
DIANA-microT web server [38–39] (http://diana.cslab.ece.
ntua.gr/pathways/) was employed in order to find potential target
genes for this novel miRNA. The hsa-mir-6165 prediction was also
performed by using MatureBayes [40], pmirp [41] and mirz [42]
online tools. To search for a putative promoter sequence upstream
of (pri-mir-6165) gene, Promoter 2.0 Prediction Server (http://
www.cbs.dtu.dk/services/Promoter/) was employed [43]. Diana-
mirpath [44] and geneset2miRNA [45] online tools used to find
the pathways in which mir-6165 is involved. To search for the co-
expression of miRNA target genes with miRNA host gene,
GENEMANIA [46] online tool was used. Gene ontology analysis
of mir-6165 potential targets was done by using Gene Ontology
Functional Analysis Tool (DAVID) [47].
Cell Culture
Hela and U87MG (both obtained from Pasteur Institute, Iran)
cell lines were cultured in RPMI-1640 media (Invitrogen),
supplemented with 10% fetal bovine serum (FBS) (Invitrogen),
100 U/ml penicillin and 100 mg/ml streptomycin (Sigma), and
incubated in 37uC with 5% CO2. NT2 cells [48] were cultured in
DMEM-HG containing 10% heat-inactivated FBS, 100 U/ml
penicillin and 100 ug/ml streptomycin.
Tissue Samples
Fresh surgical tissue biopsies of meningioma, glial, astrocytoma
and oligodendroglioma were kindly provided by Imam Hospital
[49].The samples were stored and processed as previously
described in the same reference.
RNA Extraction
Total RNA was extracted from cell lines using Trizol reagent
according to the manufacturer’s protocol (Invitrogen). Residual
DNA was removed using RNAase-free DNAase I (Takara) at 37uC
for 30 min followed by heat inactivation at 65uC for 10 min by
addition of EDTA.
Real-time PCR detection of precursor and mir-6165 mature
form.
According to the predicted precursor and mature miRNA
sequences, primers were designed for quantitative PCR (Table 1),
using NCBI primer-blast, MWG Operon online PCR primer
design tool (www.eurofinsdna.com) and primer bank (http://pga.
mgh.harvard.edu/primerbank/). Briefly, 1 ug of total RNA
Figure 2. pre-mir-6165 overexpression in the Hela cells and detection of Hsa-mir-6165 mature form. A) Schematic presentation of pre-
mir-6165 cloning, overexpression and its RNA adenylation followed by cDNA synthesis, using a universal anchored-oligo-dT primer. For the
amplification of precursor, first strand cDNA was PCR amplified using precursor specific F-primer and reverse anchor primer on the oligo-dT tail. For
the amplification of mature miRNA, predicted mir-6165 sequence was used as the forward primer. B) Hsa-mir-6165 increased production (200,000x)
following transfection of Hela cells with its precursor. In the untransfected cells (U) or scrambled control (M), the level of this miRNA was lower
compared to the transfected cells (T). C) Four sequencing result of TA vector clones containing mir-6165 real time PCR products, are compared to the
precursor sequence. The sequences between the laboratory added polyA and the upstream vector sequence are considered as mature miRNA.
Sequencing of clones #2, #3 and #4 shows that prediction of Hsa-mir-6165 sequence has been correct. Clone#1 also shows the similar sequence
plus AGG extra nucleotides which is considered an iso-mir for the miRNA.
doi:10.1371/journal.pone.0035561.g002
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PolyA polymerase (BioLab), 2 ul of 10 mMol ATP and incubated
at 37uC for 10 min. Then, the total poly adenylated RNA was
used in 10 mL first strand cDNA synthesis reaction using
PrimeScript II reverse transcriptase (Takara) and a cocktail of
specific oligo-dT primers containing a universal anchor (Table-1).
cDNA synthesis reaction was performed at 42uC for 30 min and
terminated at 80uC for 5 s. Real-time quantitative PCR was
performed using standard protocols on an ABI PRISM 7500
instrument (Applied Biosystems). Briefly, the run method profile
consisted of: stage 1, 95uC for 5 s,stage 2, 60uC for 20 s; stage 3,
72uC for 34 s. Stage 2 was repeated for 45 cycles. Continuous melt
curve stages included a first step of 95uC/15 s, step 2 at 60.0uC for
1 min, 95uC/30 s and a last step of 60uC for 15 s. Total PCR
products were cloned in TA vector (Fermentas) and were
sequenced (Genfanavaran Co.).
Overexpression of mir-6165 Precursor in Hela Cell Line
Human genomic DNA was extracted from white blood cells
using standard protocol [50]. 84 bp fragment representing the
predicted pre-miRNA was PCR amplified, using precursor
forward and reverse primers (Table 1), using PFU polymerase
(Takara) and cloned in modified pEGFP-C1 expression vector
with two CMV promoters. The 84 bp fragment was cloned in the
vector using Not1 and EcoRV restriction enzymes. Recombinant
vectors were propagated by miniprep (Qiagene Co.) and 2 ug of
this DNA was used for lipofectamin (Invitrogen) transfection of
Hela and U87 cell lines in 24 well plates containing about 2610 ˆ5
cells per well. GFP expression was visualized by a florescence
microscope (Nikon eclipse Te2000-s).
Cell Cycle Analysis
After 34 hours, the U87 and Hela cells over expressing pre-mir-
6165 were harvested and stained with propidium iodide (PI) and
Annexin V (Roche) according to the manufacturer’s protocol. All
samples were analyzed with a FACS Calibur flow cytometer with
Cell Quest software (BD Biosciences). All assays were carried out
in duplicates.
Statistical Analysis
Real time experiments were run in duplicates. Real time data
were analyzed using DDCT method by DataAssist software V3.0
and normalized by endogenous control U48 small nucleolar RNA
gene (SNORD48) and B2m or globalization method [51]. Other
statistical analysis was performed with GraphPad Prism 5.04
(GraphPad, San Diego, CA). For apoptosis studies, data showing
percent of early apoptotic cell population within negative group
and test group, compared with each other by Repeated Measures
ANOVA test, and followed by Bonferroni test using GraphPad.
Data were considered statistically significant, when P-values were
,0.05.
Results and Discussion
Prediction of a Novel Intronic miRNA Within the Human
NGFR Gene
Due to their implications in several diseases including cancer,
miRNAs are under intensive research aiming at novel pharma-
cological interventions. Computational tools have been used for
efficient prediction of novel miRNAs and their target genes [30].
After several failed PCR attempts to amplify the area spanning the
4
th intron of rat NGFR gene, chr10: 84267661–84265746[-]
UCSC nov.2004 (Baylor 34 rn4), we used mFOLD program
(http://mfold.rna.albany.edu) to search for possible hairpin
structures in this region. This program introduced multiple
hairpin structures in the 4
th intron of NGFR genes both in
human and rat genomes. Using miRNA prediction HMM based
tool (SCC profiler), several potential miRNA precursors were
identified, however, only one of them, named pre-mir-6165,
showed the criteria of producing a real human intronic miRNA
locating; hg19, chr17: 47588166 – 47588269 (Figure 1A).
Microprocessor SVM program also predicted a Dorsha processing
site for pre-mir-6165 (Figure 1B). To date for mir-6165, no
identical miRNA has been reported in the mirbase database,
except a weak resemblance to mir-328a in rat and mouse.
Furthermore, Mireval online tool identified this novel precursor
with strong conservation and with no homology to other miRNAs.
Using blast search, it was demonstrated that both sequence and
structure of pre-mir-6165 was conserved in mammals, while mir-
6165 was mostly conserved in primates (Figure 1C). Overall,
accumulated bioinformatics evidences suggested the existence of a
novel microRNA. Firstly, CIDMIR, Pmirp, MatureBayes, miR-
abela -MirZ and Microprocessor SVM softwares all recognized
pre-mir-6165 with significant scores. These tools consider
conservation, expression level and other characters in order to
predict the possibility of a miRNA production. Secondly,
precursor sequence as a query produced 9 hits with 100% identity
at the level of 20–27 bp in the Blat search against human genome.
Four of these yet uncharacterized hits show common characters of
mir-precursors and are very similar to the already reported
miRNA precursors in the mirbase database. Others have used
similar method for the discovery of new miRNAs [32]. Thirdly,
conservation of seed [52] as well as the rest of mir-6165 sequence
in human genome is a strong bioinformatics supporting evidence
for the presence of this miRNA (Figure 1C). This miRNA is not
clustered and is weakly conserved between taxa, the same property
is already reported for certain miRNAs which are not conserved
[53], not clustered [54], have temporal and cell-specific expression
patterns [55], and have no homology to other miRNAs [35].
Overexpressed pre-mir-6165 is Efficiently Processed in
the Hela Cells
According to the Oncomine [56], the database for the
expression profile of the genes, NGFR gene expression (and as a
result pre-mir-6165) is very low in Hela cell line. In an attempt to
overexpress pre-mir-6165 in Hela cells and check for the
production of mature mir-6165, a corresponding 84 bp DNA
fragment was amplified by PCR from human genomic DNA and
ligated to the pEGFP-C1 modified expression vector under CMV
promoter (Figure 2A). The same vector without insert and/or
containing scramble DNA, were used as a negative controls in
further experiments. Transfection rate of these cells was monitored
via fluorescent emission of GFP, and the best transfected culture
was used for RNA extraction and gene expression studies. In Hela
cells which were transfected with the pre-mir-6165 construct the
level of mature mir-6165 elevated by a factor of 200,000 fold. The
result indicates that mir-6165 precursor cloned under CMV
promoter is efficiently expressed and processed to a mature form
(Figure 2B). Mature mir-6165 real-time PCR products showed an
expected size on the acrylamid gel and were subsequently cloned
in the TA vector for sequencing. The sequencing results of three
independent clones showed the exact sequence of expected mir-
6165 before polyA tail, indicating correct prediction of 39-end of
the miRNA (Figure 2C). On the other hand, sequencing result
from one of the TA clones showed 2 bp extra nucleotides after the
predicted 39 end for mir-6165. This might be the result of subtle
variation in the RNA ends corresponding to Drosha and Dicer
cleavage sites.
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base under the extension number of; [EBI accession#: FR873488,
FR873489]. Overall, these experiments demonstrate that Hela
cells are able to process the predicted pre-mir-6165 to its predicted
mature miRNA form.
Experimental Detection of Endogenous mir-6165 and its
Precursor in Glioma Cell Lines and Brain Tumors
Promoter 2.0 Prediction Server did not predict an independent
promoter for mir-6165, therefore, its transcription is supposed to
be through NGFR host gene promoter. NGFR is expressed shortly
Figure 3. Detection of Hsa-mir-6165 in the brain derived cell lines and biopsies. A) NGFR and mir-6165expression profile in some glioma
cell lines is compared to non-glioma NT2 cell line Daoy, 1321N1, U87 (glioma cell lines) and NT2 (non glioma cell line) were used for detection of Hsa-
mir-6165 expression. U48 small neucleolar RNA was used as internal control for the amplifications. In glioma cell lines Hsa-mir-6165 expression level
was higher than NT2 cell line. B) Relative, Hsa-mir-6165 and its precursor expression levels in various human glioma tissue samples. The expression
level of Hsa-mir-6165 in the tumor samples were compared to the lowest grade of tumors. U48 small nucleolar RNA gene (SNORD48) was used for
normalizing the expression levels. Error bars indicate standard deviation (SD) of duplicate experiments. Pearson’s test confirmed a positive correlation
between NGFR and its intronic miRNA (p=0.0065). In all of the high grades (HG) tissue samples, the level of NGFR and mir-6165 were higher than the
low grad (LG) samples.
doi:10.1371/journal.pone.0035561.g003
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35561Figure 4. mir-6165 overexpression in U87 cell line induces apoptosis. A) PI staining of U87 cells 34 hours post transfection was done to
investigate the effect of mir-6165 on cell cycle. A dramatic change was observable toward sub-G1 stage in the cells overexpressing mir-6165
compared to negative controls (a9-d 9).B) Annexin-PI staining of the U87 cells overexpressing mir-6165 shows, the most of the cells have entered early
apoptosis stage compared to negative control and the result is consistent with PI staining in the previous section (a0-d 0). The gate setting
distinguished between living (bottom left), necrotic (top left), early apoptotic (bottom right), and late apoptotic (top right) cells. Repeated Measures
ANOVA analysis shows that the changes observed in flow cytometry of U87 cells is extremely significant (p,0.05) between negative controls and the
cells overexpressing mir-6165 (e0).
doi:10.1371/journal.pone.0035561.g004
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35561Figure 5. mir-6165 overexpression in Hela cell line. A) PI staining of Hela cells overexpressing Hsa-mir-6165 did not show any significant
change in the stages of cell cycle after 34 hours post transfection (a9-c 9). B) Annexin-PI staining of the Hela cells shown in figures a0-d 0. Repeated
Measures ANOVA analysis shows that the changes observed in annexin test of Hela cells were not significant between negative controls (scramble)
and the test group (e0).
doi:10.1371/journal.pone.0035561.g005
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expressed at a detectable level in the human Glioblastoma U87-
MG cell line [15,56]. For this reason, U87-MG and other
glioblastoma cell lines were chosen for the experimental detection
of mir-6165 and its precursor. The fact that one or both of mir and
miRNA-star sequence (miRNA*), the complementary strands of
functional mature miRNA, might exert function, two primers were
designed; one exactly identical to the predicted mir-6165 (called
Pm1 primer, Table-1) and the second primer was identical to its
complementary mir* (called Pm1* primer). After Poly-A addition
to the total RNA extracted from several glioblastoma cell lines,
cDNA was synthesized using anchored oligodT primer (Table-1).
Later along with NGFR gene, the mature form of mir-6165 was
amplified from RNA samples of Daoy, 1321N1, U-87 and NT2
cell lines, using Pm1 primer (Figure 3A). In this figure, mir-6165
expression in Daoy, 1321N1, U87 (brain tumor-derived) cell lines
are compared to a non-glioma (a human teratocarcinoma, NT2)
cell line. mir-6165 and its host gene (NGFR) showed higher
expression level in the brain tumor-derived cell lines, compared to
the NT2 cells. This data supports the correct prediction of mir-
6165 at the first place and also points to the origin of the cells
(glioma) which express this miRNA at a detectable level.
Further supporting evidences were provided through the
detection of endogenous precursor and mature form of mir-6165
in the brain tumor biopsies (Figure 3B). mir-6165 endogenous
expression was detected using real-time PCR on seven brain
tumor tissue samples. Expression data was normalized using U48
endogenous control, and using one of the lowest degree
meningioma samples as a reference. Along with the clear detection
of endogenous mir-6165 in these tissue samples, a strong
correlation was observed between mir-6165 and NGFR gene
expression, which was further confirmed with Pearson’s test
(p=0.0065). In all of the high grade tissue samples, the level of
NGFR and mir-6165 were higher than the low grade samples
(Figure 3B).
In a neurotrophin-dependent manner, NGFR has been
suggested as an important regulator of glioma invasion [15]. In
that report, NGFR-positive cells within the glioma tumor samples
are more migratory than the NGFR-negative glioma cells.
Consistent with that report, we have seen upregulation of NGFR
in higher grades of brain tumors.
A possible molecular mechanism in which mir-6165 co-operates
with NGFR toward glioma invasion remains unknown; however,
analysis of putative targets of mir-6165 by DAVID software [47]
showed .50% of the predicted targets genes are those expressed
in brain related tissues (Figure S1) among them Pkd1 and DAGLA
genes were down regulated in tested tumor samples (data not
shown).
Cell Death Effect of pre-mir-6165 Overexpression in U87
Cell Line
In order to examine the effect of pre-mir-6165 overexpression
on the rate of apoptosis induction in the transfected cells, flow
Table 2. Top ten predicted targets for novel Hsa-mir-6165
according to DIANAmicro T v.3.
Rank Gene name Ensembl Gene Id
miTG
score Precision SNR
1 DAGLA ENSG00000134780 19.21 0.82 3.97
2 PKD1 ENSG00000008710 18.00 0.82 3.97
3 ENSG00000196518 18.00 0.82 3.97
4 LRRC27 ENSG00000148814 18.00 0.82 3.97
5 KIAA0258 ENSG00000107185 16.09 0.78 3.97
6 VANGL2 ENSG00000162738 16.00 0.78 3.97
7 RHPN1 ENSG00000158106 16.00 0.78 3.97
8 WDTC1 ENSG00000142784 15.00 0.78 3.97
9 ENSG00000138944 15.00 0.78 3.97
10 MECP2 ENSG00000169057 15.00 0.78 3.97
The Signal to noise ratio (SNR) is calculated by the DIANA-microT algorithm and
is based on a comparative analysis of the real miRNA versus a set of mock
miRNAs. Higher miTG scores correspond to higher possibility of correct
prediction. Greater values of SNR correspond to better distinction from the
mock background [38].
doi:10.1371/journal.pone.0035561.t002
Figure 6. Down regulation of hsa-mir-6165 target genes following its precursor overexpression. Down regulation of DAGLA and Pkd1
predicted target genes following the overexpression of Hsa-mir-6165 compared to the scrambled negative controls. Data of expression were globally
normalized against U48, U6 and B2m as endogenous controls.
doi:10.1371/journal.pone.0035561.g006
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annexin. This method has been reliably used to show the
involvement of miR-16, let-7a and miR-34a in apoptosis [57].
Compared to the mock transfected control cells, no statistically
significant apoptosis induction was detected 34 hours post
transfection in Hela cells using PI staining. However, transfected
U87 cells showed more than 10% elevation in sub-G1 cell
population (Compare figure 4A with 5A). P value for such
increased cell death rate was calculated by Repeated Measures
ANOVA analysis and the results were highly significant
(p=0.0009). Annexin test shows the early apoptosis rate of the
transfected cells and is more sensitive than PI test. This test showed
,40% of the transfected U87 cells were in early apoptosis
(p=0.003) (Figure 4B). Overall, our results suggest a pro-apoptotic
role for mir-6165 in the U87 cells, but not in the Hela cell line
(Figure 5).
Lack of significant apoptotic effect of mir-6165 in transfected
Hela cells may be due to the cellular environment or context of the
cell [58] or lack of its partner(s) or target(s) in this cell line.
Accumulative experimental evidences from the detection of
endogenous mature mir-6165 in the brain tumor samples to the
detection of exogenous mir-6165 in the transfected Hela cells and
its overexpression effect on the cell death rate, all emphasis the
functionality of this miRNA.
Down Regulation of Predicted mir-6165 Target Genes
upon its Overexpression
The sequence of mir-6165 was used as query for target
prediction in DIANA-microT online tool and its top ten candidate
genes are listed in Table 2. In the glioblastoma cell lines in which
NGFR and mir-6165 are expressed, some of these target genes are
down regulated based on the information from Oncomine
database. DAGLA gene (Neural stem cell-derived dendrite
regulator) is the highest scored target gene of the list and its
miRNA recognition element (MRE) is highly conserved among
other organisms. The interaction between this target and mir-6165
was further analyzed using RNAHybride (http://bibiserv.techfak.
uni-bielefeld.de) online tool. Strong complementation was ob-
served between the mir-6165 and its target MRE element in the
DAGLA gene.
For experimental verification of the mir-6165 target genes, real-
time specific primers were designed for (DAGLA and PKD)
predicted target genes. Overexpression of pre-mir-6165 in Hela
cells ended in 200,000 fold increase of mature form, 34h post
transfection but DAGLA and PKD expression level still remained
undetectable. In contrast to Hela cells, DAGLA and PKD genes
were expressed at a detectable level in the untransfected U87 cells.
Upon overexpression of mir-6165 in the U87 cells, a significant
down regulation of these target genes was observed (Figure 6).
Mutations in the PKD1 gene (encoding Polycistin-1) are
accounted for the renal cysts formation [59]. Overexpression of
PKD1 in Madin-Darby canine kidney (MDCK) cells has led to
decreased apoptosis [60] and silencing of PKD1 has led to an
increased apoptosis rate due to a reduced cell adhesion [61].
PKD1 and PKD2 are expressed in a number of tissues and organs,
including the ductal epithelial cells in the kidney, liver, pancreas,
breast, smooth muscle, endothelial cells of the vasculature and
astrocytes in the brain [62]. U87 cell line is an astrocytoma cell
line derived from a human malignant glioma and we showed that
PKD1 was expressed in this cell line (Figure 6). Consistent with
previous studies as well as considering high expression level of
PKD1 in most of the brain tumor-derived cell lines, a reduction in
PKD1 expression following the overexpression of mir-6165 could
justify the increased rate of apoptosis and a change of cell number
distribution toward sub-G1 (Figure 4).
DAGLA gene is involved in endocannabinoid pathway shown
by mouse knock out model. This pathway refers to a group of
neuromodulatory lipids and their receptors [63]. DAGLA gene
effect on proliferation is not yet clear to our knowledge. A recent
publication has suggested that DAGLA deletion ended in ,50%
less cell proliferation of the hippocampus cells [63]. DAGLA gene
has multiple target sites for mir-6165 within its 39-UTR and it is
deducible that overexpression of this miRNA has caused down
regulation of this target gene at least at the mRNA level (Figure 6).
It is remained to be tested if increased rate of apoptosis is related to
the down regulation of DAGLA gene as well.
Co-expression of mRNAs and/or functional similarity of target
and host genes of an intronic miRNA have been hypothesized
[64]. This hypothesis was tested for NGFR and mir-6165
predicted target genes using GENEMANIA database (Figure
S2). There was a co-expression pattern between most of the targets
and NGFR host gene while none of the high scored targets show a
direct physical interaction with NGFR gene.
It has been suggested that intronic miRNAs tend to target the
genes that are functionally similar to their host genes [64]. Using
Funsimmat algorithm (funsimmat.bioinf.mpi-inf.mpg.de) high
scored target genes of mir-6165 showed functional similarity with
NGFR gene as well. Noteworthy, Diana-mirpath and geneset2-
miRNA online servers showed that most of the first 20 high scored
targets of mir-6165 are also targeted by other miRNAs involved in
cancers and brain development like mir-608, mir24 and mir-637.
How this network of miRNAs with overlapped functions act in
cancerous cell and development remain to be tested.
In conclusion, by multiple experimental evidence, our study
revealed that mir-6165 is expressed in brain tumor-derived cell
lines and primary brain tumor tissues. Overexpression of mir-6165
in U87 cell line increased the cell death rate and down regulated
PKD1 and DAGLA target genes, which are involved in apoptosis.
Furthermore, there is a strong co-expression network of mir-6165
host and target genes.
Supporting Information
Figure S1 Co-expression network of NGFR gene with
mir-6165predicted targets. Although there is a co expression
network between targets genes of mir-6165 but none of these
targets have direct interaction with NGFR host gene. The targets
of mir-6165have been shown by the larger nodes.
(TIF)
Figure S2 Percent of putative targets of Hsa-mir-6165 in
different tissues. Analysis of mir-6165 putative target genes by
DAVID showed more than 50 percent of predicted target genes
are expressed in brain related tissues.
(TIF)
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